<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04812444</url>
  </required_header>
  <id_info>
    <org_study_id>ZYLOX-02</org_study_id>
    <nct_id>NCT04812444</nct_id>
  </id_info>
  <brief_title>Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion</brief_title>
  <official_title>Safety and Efficacy of Peripheral Venous Stent System in the Treatment of Patients With Iliac Vein Stenosis or Occlusion: a Prospective, Multicentre, Randomized Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang Zylox Medical Device Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang Zylox Medical Device Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical study on safety and efficacy of Zylox peripheral venous stent system in the&#xD;
      treatment of iliac vein stenosis or occlusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study was to evaluate the safety and efficacy of Zylox peripheral venous&#xD;
      stent system in the treatment of iliac vein stenosis or occlusive lesions compare with&#xD;
      conventional venous stent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2020</start_date>
  <completion_date type="Anticipated">September 2027</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target vascular patency rate at 12 months after operation</measure>
    <time_frame>12 months</time_frame>
    <description>Target vascular patency rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of major adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Related to death of clinical trials</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event</measure>
    <time_frame>Preoperative、Intraoperative、up to 1 month、3 month、6 month、12 month、2 years、3 years、5 years</time_frame>
    <description>Adverse medical events,whether or not related to the medical device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Iliac Vein Stenosis</condition>
  <condition>Iliac Vein Occlusion</condition>
  <arm_group>
    <arm_group_label>Zylox Peripheral Venous Stent Implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous stent placement in the iliofemoral veins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Zilver Vena Venous Stent Implantation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Percutaneous stent placement in the iliofemoral veins</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zylox Peripheral Venous Stent</intervention_name>
    <description>Self-expanding stent implantation during the index procedure.</description>
    <arm_group_label>Zylox Peripheral Venous Stent Implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zilver Vena Venous Stent</intervention_name>
    <description>Self-expanding stent implantation during the index procedure.</description>
    <arm_group_label>Zilver Vena Venous Stent Implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged from 18 to 75 years old, male or female&#xD;
&#xD;
          -  Subject's target lesions were stenosis and/or occlusion&#xD;
&#xD;
          -  CEAP≥C3&#xD;
&#xD;
          -  Subjects were able to understand the purpose of the study, demonstrate full compliance&#xD;
             with the program and sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman or who's pregnancy test is positive&#xD;
&#xD;
          -  Lactation period woman or woman/man with fertility plan&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu Zhao</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jie Liang</last_name>
    <phone>13819565660</phone>
    <email>jie.liang@zyloxmedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Zhao</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peripheral venous stent system</keyword>
  <keyword>Iliac vein patency rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

